Literature DB >> 15935394

Mechanisms of oleic acid deterioration in insulin secretion: role in the pathogenesis of type 2 diabetes.

Yali Zhang1, Meifang Xiao, Gang Niu, Huanran Tan.   

Abstract

Obesity is highly associated with type 2 diabetes where free fatty acids (FFAs) may be a trigger factor. To examine this hypothesis, in this study, we investigated the role of FFAs in the pathogenic development of type 2 diabetes. The release of insulin, the expression of preproinsulin (PPI), glucose transporter2 (GLUT2) and pancreatic duodenal homeobox-1 (PDX-1), and levels of intracellular free Ca++([Ca++]i) were measured in rat pancreatic islets treated with or without high concentrations of FFA (0.1 and 1.0 mM oleic acid) for 24 h. In comparison with untreated control, islets exposed to oleic acid showed an increase in basal insulin release and a decrease in glucose induced insulin secretion (GSIS). Elevated expression of PPI, PDX-1 and GLUT2 was also observed after treatment of the islets with oleic acid, which may partially contribute to the increased basal insulin secretion. Moreover, [Ca++]i levels increased after oleic acid exposure, which most likely accounts for the decrease of GSIS. Our findings, thus strongly suggest, that the increased levels of basal insulin secretion involved in glucose sensing, insulin producing and insulin secreting induced by high levels of FFAs may cause hyperinsulinemia in patients with type 2 diabetes, and thus long-term hyperinsulinemia could desensitize insulin receptors. We hypothesize that hyperinsulinemia may be a primary and independent event in the pathogenesis of diabetes. If proven, it may be possible to create novel and effective approaches for the prevention and treatment of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935394     DOI: 10.1016/j.lfs.2004.12.047

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes.

Authors:  Marlon E Cerf
Journal:  Endocrine       Date:  2013-03-13       Impact factor: 3.633

2.  Anthocyanins-rich extract of wild Chinese blueberry protects glucolipotoxicity-induced INS832/13 β-cell against dysfunction and death.

Authors:  Jia Liu; Fengyi Gao; Baoping Ji; Ruojun Wang; Junsi Yang; Huijun Liu; Feng Zhou
Journal:  J Food Sci Technol       Date:  2014-04-26       Impact factor: 2.701

3.  Stress-induced dissociations between intracellular calcium signaling and insulin secretion in pancreatic islets.

Authors:  Farhan M Qureshi; Eden A Dejene; Kathryn L Corbin; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2015-03-23       Impact factor: 6.817

4.  The minor C-allele of rs2014355 in ACADS is associated with reduced insulin release following an oral glucose load.

Authors:  Malene Hornbak; Karina Banasik; Johanne M Justesen; Nikolaj T Krarup; Camilla H Sandholt; Åsa Andersson; Annelli Sandbæk; Torsten Lauritzen; Charlotta Pisinger; Daniel R Witte; Thorkild A A Sørensen; Oluf Pedersen; Torben Hansen
Journal:  BMC Med Genet       Date:  2011-01-06       Impact factor: 2.103

5.  Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats.

Authors:  Lu Zheng; Yuehua Feng; Yuanping Shi; Jun Zhang; Qinfeng Mu; Li Qin; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Guanghua Luo; Ning Xu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with Ficus deltoidea and vitexin.

Authors:  Samsulrizal Nurdiana; Yong Meng Goh; Hafandi Ahmad; Sulaiman Md Dom; Nur Syimal'ain Azmi; Noor Syaffinaz Noor Mohamad Zin; Mahdi Ebrahimi
Journal:  BMC Complement Altern Med       Date:  2017-06-02       Impact factor: 3.659

7.  Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

Authors:  Christopher D Green; Donald B Jump; L Karl Olson
Journal:  Endocrinology       Date:  2009-02-19       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.